+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Therapeutic Antibiotics for Food Animals Market by Animal Type, Product Type, Application Mode, End Use, Formulation, Sales Channel - Global Forecast to 2030- Product Image
Non-Therapeutic Antibiotics for Food Animals Market by Animal Type, Product Type, Application Mode, End Use, Formulation, Sales Channel - Global Forecast to 2030- Product Image
Sale

Non-Therapeutic Antibiotics for Food Animals Market by Animal Type, Product Type, Application Mode, End Use, Formulation, Sales Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337508
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-Therapeutic Antibiotics for Food Animals Market grew from USD 5.13 billion in 2024 to USD 5.52 billion in 2025. It is expected to continue growing at a CAGR of 7.20%, reaching USD 7.80 billion by 2030.

Understanding the Non-Therapeutic Antibiotics Landscape in Food Animals

The use of non-therapeutic antibiotics in food animal production has become a focal point of debate among industry stakeholders, regulators, and consumers. As global demand for protein rises, producers are seeking ways to maximize efficiency, minimize disease risk, and maintain animal welfare standards. Non-therapeutic applications of antibiotics-whether for growth promotion or routine prophylaxis-play a pivotal role in this dynamic.

Over the last decade, public health authorities and advocacy groups have intensified scrutiny over antimicrobial resistance, placing pressure on manufacturers, distributors, and farmers to adapt. Advances in microbiology have shed light on the mechanisms by which antibiotic use in aquaculture, cattle, poultry, and swine can contribute to resistant bacterial strains. Simultaneously, evolving regulatory frameworks across major markets demand that industry participants demonstrate stewardship, transparency, and measurable progress toward reducing non-therapeutic reliance.

This executive summary synthesizes the core trends, shifting market forces, tariff implications, segmentation nuances, regional variations, and key company strategies. It establishes the foundation for strategic decision-making in an era defined by both unprecedented opportunity and significant regulatory, environmental, and public health challenges.

Driving Forces Shaping the Market Transformation

The landscape of non-therapeutic antibiotic use in food animal production is undergoing transformative shifts driven by innovation, policy, and consumer sentiment. Advances in microbiome science have paved the way for precision dosing strategies and targeted delivery systems that reduce overall antibiotic volumes while maintaining efficacy. Novel feed additives and water‚soluble formulations are replacing broad-spectrum applications, enabling more selective interventions aligned with animal type and specific health parameters.

Regulatory bodies across the globe are harmonizing guidelines to address antimicrobial resistance, compelling suppliers and end users to adopt integrated monitoring systems. The industry is witnessing a surge in digital tracking platforms that record dosage, animal response, and residue levels, allowing stakeholders to respond proactively. These platforms support compliance with stringent reporting requirements and provide the data backbone for ambitious reduction targets set by both public and private sector actors.

Consumer preferences are concurrently shifting, as end users of animal protein demand transparency regarding antibiotic stewardship. Leading retailers are forging partnerships with producers that commit to reduced-antibiotic protocols, fueling adoption of alternative growth promotion strategies and vaccination programs. This confluence of scientific, regulatory, and market forces is redefining competitive advantage in the sector: suppliers who can deliver validated efficacy, traceability, and compliance will emerge as preferred partners in a value chain under relentless scrutiny.

Assessing the 2025 US Tariffs and Market Ripple Effects

The implementation of new U.S. tariffs in 2025 marks a significant inflection point for stakeholders in the non-therapeutic antibiotic sector. These measures, aimed at balancing trade dynamics and safeguarding domestic producers, have introduced additional duties on selected antibiotic classes. Companies dependent on imported active pharmaceutical ingredients must now navigate increased input costs and recalibrate supply chains to mitigate margin compression.

Producers of aminoglycosides, particularly gentamicin and streptomycin, face heightened sourcing complexities, driving some manufacturers to explore domestic synthesis partnerships. Similarly, markets for macrolides such as erythromycin have seen price volatility as tariff-induced constraints ripple through distribution channels. The combined impact has encouraged strategic alliances and licensing agreements, enabling manufacturers to localize production and avoid the most burdensome levy tiers.

While some beneficiaries of tariff protection are securing competitive footing in the domestic arena, the broader market adjustment has catalyzed innovation investments. Companies are accelerating research into next-generation penicillin derivatives and sulfonamide alternatives that may fall under different tariff classifications. Ultimately, the 2025 U.S. tariffs are not merely a cost center; they are a catalyst compelling industry participants to strengthen supply resilience, diversify sourcing, and prioritize R&D for future-proof antibiotic portfolios.

Unveiling Critical Segmentation Dynamics

A granular examination of the market through multiple segmentation lenses reveals intricate dynamics that industry leaders must consider when crafting strategy. Based on animal type, growth promotion efficacy varies significantly between aquaculture systems and terrestrial livestock, with poultry operations demonstrating higher uptake of water‚soluble powders while swine producers lean heavily on in-feed additives. Within product type, the choice between macrolides such as tilmicosin and tetracyclines like oxytetracycline is often informed by resistance profiles and veterinary protocols specific to each livestock segment.

Application mode insights indicate that in-water dosing platforms are gaining traction in extensive aquaculture operations, whereas in-feed formulations remain predominant in cattle and poultry environments. The divergence in end use purposes is equally revealing: prophylactic regimens are prioritized in high-density farm settings to mitigate outbreak risks, while growth promotion continues to drive adoption in markets where yield optimization is paramount. Formulation preferences underscore the importance of feed mill partnerships for large integrated producers, contrasted with veterinary distributors supplying oral suspensions to smallholder farms.

Sales channel dynamics further underscore the complexity of the distribution landscape. Feed mills serve as critical conduits for feed-additive antibiotics, while retail pharmacies fulfill the demand for specialized oral suspensions and powdered concentrates. Veterinary distributors complete the network by catering to niche requirements and ensuring rapid availability of key compounds during peak production cycles.

Regional Market Nuances Across Global Territories

Regional disparities play a pivotal role in shaping non-therapeutic antibiotic strategies and adoption rates. In the Americas, comprehensive antibiotic stewardship programs have prompted a gradual shift away from routine growth-promotion uses, with producers exploring alternative health management solutions. Conversely, emerging markets in Asia-Pacific continue to experience robust demand for in-feed additives and water-soluble powders, driven by rapid expansion of aquaculture and integrated poultry systems.

Within Europe, Middle East & Africa, stringent regulatory frameworks and escalating public health campaigns have led to widespread adoption of in-water dosing applications in lieu of blanket in-feed regimens. Producers in this region demonstrate a clear preference for macrolides prescribed through veterinary distribution channels to ensure controlled administration and regulatory compliance. These regional nuances underscore the necessity for adaptive product portfolios and tailored go-to-market strategies that reflect local regulatory climates and supply chain infrastructures.

Profiling Leading Players and Strategic Movements

Major participants in the non-therapeutic antibiotic market are intensifying efforts to differentiate through innovation, strategic partnerships, and expanded geographic reach. Leading global formulators are investing in next-generation sulfonamide and penicillin derivatives aimed at reducing resistance risk and meeting the stringent import requirements of key markets. At the same time, vertically integrated feed mill operators are forging joint ventures with veterinary biotech firms to embed advanced dosing technologies directly into feed production lines.

Some multinational companies are pivoting toward high-value injectable formulations and specialty oral suspensions, recognizing the emergence of boutique livestock producers seeking targeted solutions. These players are also leveraging digital platforms to provide real-time usage analytics, reinforcing their value proposition with actionable insights for antibiotic stewardship. Meanwhile, regional champions are capitalizing on local manufacturing capabilities to undercut tariff-exposed imports, strengthening relationships with regional regulators and industry associations to secure early access to new product approvals.

Strategic Recommendations to Navigate Regulatory and Market Shifts

To thrive amid escalating regulatory pressures and market evolution, industry leaders must adopt a multi-pronged strategy. First, embedding robust antibiotic stewardship protocols across the value chain will enhance credibility with regulators and end consumers alike, while driving tangible reductions in non-therapeutic usage. Second, accelerating investment in localized manufacturing and forward-integrated supply chains will mitigate tariff-related cost volatility and improve resilience. Third, embracing digital tracking and analytics platforms will deliver unprecedented transparency, enabling producers to demonstrate compliance and benchmark performance against peer cohorts.

Furthermore, forging collaborative research initiatives with academic institutions and biotech firms can unlock novel antibiotic classes and alternative growth promotion modalities, differentiating portfolios in a crowded market. Finally, tailoring market entry approaches to reflect regional regulatory landscapes and distribution networks will ensure that product offerings align with on-the-ground realities. By integrating these strategic pillars, organizations can transform regulatory challenges into catalysts for innovation and sustainable growth.

Robust Research Methodology Ensuring Data Integrity

Our research methodology combines rigorous primary interviews with industry experts, veterinarians, and procurement specialists alongside exhaustive secondary research from regulatory filings, peer-reviewed journals, and trade association reports. This hybrid approach enables triangulation of qualitative insights and quantitative data, ensuring full coverage of product classes, application modes, and regional market factors.

Segment definitions are validated through cross-referencing supplier sales data, feed mill records, and import-export statistics, while demand drivers are corroborated with end user surveys spanning aquaculture, cattle, poultry, and swine segments. Tariff impact assessments utilize customs databases and trade analytics platforms, offering granular clarity on cost differentials across antibiotic classes and sourcing geographies.

Quality control measures include double-blind coding of interview transcripts, statistical validation of survey inputs, and iterative peer reviews by subject matter experts. The result is a comprehensive, reliable framework that supports strategic decision-making and risk mitigation in an industry undergoing rapid transformation.

Key Takeaways from the Executive Summary

The analysis presented in this executive summary highlights the intricate interplay of regulatory change, technological innovation, and market demand shaping the non-therapeutic antibiotic sector. As tariffs realign cost structures and stewardship expectations escalate, companies must act decisively to future-proof their operations. By leveraging segmentation insights-whether optimizing formulations for water dosing in aquaculture or aligning feed mill partnerships in poultry-producers can maintain competitive advantage.

Regional nuances underscore the imperative for tailored approaches, while leading companies demonstrate that strategic alliances and digital capabilities are no longer optional. The path forward demands a holistic blend of operational excellence, scientific innovation, and proactive compliance. Those who embrace these imperatives will not only navigate the current landscape but also define the industry’s next chapter in sustainable, responsible animal production.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Aquaculture
    • Cattle
    • Poultry
    • Swine
  • Product Type
    • Aminoglycosides
      • Gentamicin
      • Neomycin
      • Streptomycin
    • Macrolides
      • Erythromycin
      • Tilmicosin
      • Tylosin
    • Penicillins
      • Amoxicillin
      • Ampicillin
      • Penicillin G
    • Sulfonamides
      • Sulfadiazine
      • Sulfamethazine
      • Sulfamethoxazole
    • Tetracyclines
      • Chlortetracycline
      • Oxytetracycline
      • Tetracycline
  • Application Mode
    • In Feed
    • In Water
  • End Use
    • Growth Promotion
    • Prophylaxis
  • Formulation
    • Feed Additives
    • Oral Suspensions
    • Water Soluble Powders
  • Sales Channel
    • Feed Mills
    • Retail Pharmacies
    • Veterinary Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Huvepharma S.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-Therapeutic Antibiotics for Food Animals Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.3. Cattle
8.4. Poultry
8.5. Swine
9. Non-Therapeutic Antibiotics for Food Animals Market, by Product Type
9.1. Introduction
9.2. Aminoglycosides
9.2.1. Gentamicin
9.2.2. Neomycin
9.2.3. Streptomycin
9.3. Macrolides
9.3.1. Erythromycin
9.3.2. Tilmicosin
9.3.3. Tylosin
9.4. Penicillins
9.4.1. Amoxicillin
9.4.2. Ampicillin
9.4.3. Penicillin G
9.5. Sulfonamides
9.5.1. Sulfadiazine
9.5.2. Sulfamethazine
9.5.3. Sulfamethoxazole
9.6. Tetracyclines
9.6.1. Chlortetracycline
9.6.2. Oxytetracycline
9.6.3. Tetracycline
10. Non-Therapeutic Antibiotics for Food Animals Market, by Application Mode
10.1. Introduction
10.2. in Feed
10.3. in Water
11. Non-Therapeutic Antibiotics for Food Animals Market, by End Use
11.1. Introduction
11.2. Growth Promotion
11.3. Prophylaxis
12. Non-Therapeutic Antibiotics for Food Animals Market, by Formulation
12.1. Introduction
12.2. Feed Additives
12.3. Oral Suspensions
12.4. Water Soluble Powders
13. Non-Therapeutic Antibiotics for Food Animals Market, by Sales Channel
13.1. Introduction
13.2. Feed Mills
13.3. Retail Pharmacies
13.4. Veterinary Distributors
14. Americas Non-Therapeutic Antibiotics for Food Animals Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Non-Therapeutic Antibiotics for Food Animals Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Elanco Animal Health Incorporated
17.3.3. Merck & Co., Inc.
17.3.4. Boehringer Ingelheim International GmbH
17.3.5. Ceva Santé Animale S.A.
17.3.6. Virbac S.A.
17.3.7. Vetoquinol S.A.
17.3.8. Dechra Pharmaceuticals PLC
17.3.9. Phibro Animal Health Corporation
17.3.10. Huvepharma S.A.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET MULTI-CURRENCY
FIGURE 2. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET MULTI-LANGUAGE
FIGURE 3. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 76. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 78. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 79. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 80. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 81. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 82. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 83. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 84. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 143. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 145. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 146. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 149. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 156. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 157. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 159. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 160. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 178. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 179. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 180. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 181. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 182. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 183. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 184. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 187. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 189. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 190. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 191. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 192. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 193. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 194. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 195. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 231. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 233. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 234. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 237. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 239. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 240. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 253. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 255. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 256. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 257. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 258. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 259. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 260. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 261. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 262. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 266. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 267. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 269. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 270. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 272. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Non-Therapeutic Antibiotics for Food Animals market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Huvepharma S.A.

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.8 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Veterinary Antibiotics Market by Class, Animal Type, End-User, Therapeutic Areas - Global Forecast to 2030 - Product Image

Veterinary Antibiotics Market by Class, Animal Type, End-User, Therapeutic Areas - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Animal Antibiotics & Antimicrobials Market by Class, Animal Species, Administration Route, Formulation, Distribution Channel - Global Forecast to 2030 - Product Image

Animal Antibiotics & Antimicrobials Market by Class, Animal Species, Administration Route, Formulation, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Animal Antibiotics and Antimicrobials - Global Strategic Business Report - Product Image

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030 - Product Image

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030

  • Report
  • 258 Pages
  • Global
From
Global Feed Antibiotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Feed Antibiotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 135 Pages
  • Global
From

About the Non Therapeutic Animal Antibiotics Market

Non-therapeutic animal antibiotics are a type of animal feedstuff used to promote growth and prevent disease in livestock. They are typically added to feed in low doses to prevent the spread of disease and to increase the efficiency of feed conversion. Non-therapeutic antibiotics are used to supplement the natural immunity of animals, and to reduce the risk of infection from bacteria, viruses, and parasites. They are also used to reduce the cost of production and to improve the quality of meat and milk products. Non-therapeutic animal antibiotics are regulated by the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA). The FDA has established guidelines for the use of these antibiotics in animal feedstuffs, and the EPA has established limits on the amount of antibiotics that can be used in animal feed. Some of the major companies in the non-therapeutic animal antibiotics market include Bayer AG, Elanco Animal Health, Merck & Co., Inc., Zoetis, Inc., and Novartis AG. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.